Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × inavolisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 1 PIK3CA-Mutated Cancers 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Metastatic Castration-Resistant Prostate Cancer 1 HER2-positive Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 79 Carboplatin 63 pembrolizumab 57 Bevacizumab 24 Cisplatin 23 Surveys and Questionnaires 20 Radiotherapy 19 Letrozole 19 Doxorubicin 18 olaparib 17 Megestrol Acetate 17 lenvatinib 16 Specimen Handling 16 dostarlimab 15 Taxes 15 Nivolumab 14 Observation 13 Metformin 13 Magnetic Resonance Spectroscopy 13 Docetaxel 13 Fulvestrant 11 Blood Specimen Collection 11 durvalumab 10 Medroxyprogesterone Acetate 10 Brachytherapy 10 Biopsy 10 temsirolimus 9 abemaciclib 9 Trastuzumab 9 Radiation 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04486352 2025-09-04

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡